Literature DB >> 8915402

Effects of oral taurine supplementation on lipids and sympathetic nerve tone.

S Mizushima1, Y Nara, M Sawamura, Y Yamori.   

Abstract

OBJECTIVES: To assess effects of oral taurine supplementation on lipids and sympathetic nerve tone in healthy young men on experimental high fat and cholesterol diets.
METHODS: Twenty-two healthy male volunteers, aged 18-29 years, were recruited for this randomized control trial after informed consent according to the Ethical Committee of Shimane Medical University. Volunteers were randomly allocated into 2 study groups and given experimental diet of identical regimen [total calorie 2500 kcal, cholesterol 1000 mg, polyunsaturated fat/saturated fat (P/S) ratio 0.52, fat 40% of total energy intake (%E), protein 14%E, carbohydrate 46%E] to raise serum cholesterol (CHO) level for 3 weeks. Alcohol intake, smoking and strenuous physical activities were prohibited. Taurine powder (6 g/day) was supplied to one group (T-group, N = 11) and placebo capsules to the other (C-group, N = 11), by a single-blind approach. Blood samples and 24 h urine specimens were obtained once every week. Two men in the C-group dropped out due to upper respiratory infection. There were no difference in age, body mass index (BMI) or blood pressure (BP) between the groups. Statistical analysis was performed by analysis of variance (ANOVA, repeated measurement) and Student's t-test.
RESULTS: There were no changes in BMI and BP in either group during the period. Significant increases in total CHO (25.4 +/- 17.5 mg/dl, mean +/- SD), LDL-CHO (17.1 +/- 14.5) and LDL (43.9 +/- 37.6) were observed in C-group but were attenuated in the T-group. The T-group showed significant increases in VLDL-CHO, VLDL and TG. The T-group had significantly lower urinary norepinephrine excretion than the C-group in the last week.
CONCLUSION: Oral taurine supplementation attenuated increases in T-CHO, LDL-CHO and LDL in healthy men on high fat cholesterol diets but induced significant increases in VLDL-CHO, VLDL and TG, which could be explained by a possible effect of taurine on lipoprotein lipase. Significantly lower urinary norepinephrine excretion observed by the taurine administration implies the suppression of the sympathetic nervous system.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8915402     DOI: 10.1007/978-1-4899-0182-8_68

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  17 in total

1.  Antagonism between curcumin and the topoisomerase II inhibitor etoposide: a study of DNA damage, cell cycle regulation and death pathways.

Authors:  Ekram M Saleh; Raafat A El-awady; Nadia A Eissa; Wael M Abdel-Rahman
Journal:  Cancer Biol Ther       Date:  2012-08-16       Impact factor: 4.742

2.  Serum taurine and risk of coronary heart disease: a prospective, nested case-control study.

Authors:  Oktawia P Wójcik; Karen L Koenig; Anne Zeleniuch-Jacquotte; Camille Pearte; Max Costa; Yu Chen
Journal:  Eur J Nutr       Date:  2012-02-10       Impact factor: 5.614

Review 3.  The potential protective effects of taurine on coronary heart disease.

Authors:  Oktawia P Wójcik; Karen L Koenig; Anne Zeleniuch-Jacquotte; Max Costa; Yu Chen
Journal:  Atherosclerosis       Date:  2009-06-11       Impact factor: 5.162

4.  Investigation of Taurine Derivative Magnesium-Bis-(2-Aminoethanesulfonic)-Butadioateon Alleviation of Neurological Defects in Simulated Hemorrhagic Stroke in Rats.

Authors:  N I Nesterova; E A Patrakhanov; V V Pokrovskii; I V Pirozhkov; T G Pokrovskaya; N B Levit; M I Ivanova; S N M Kizi; A V Nesterov; V I Shutov; Y A Hoshchenko
Journal:  Arch Razi Inst       Date:  2021-10-31

5.  Perinatal taurine depletion increases susceptibility to adult sugar-induced hypertension in rats.

Authors:  Sanya Roysommuti; Atchariya Suwanich; Dusit Jirakulsomchok; J Michael Wyss
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

Review 6.  Taurine in health and diseases: consistent evidence from experimental and epidemiological studies.

Authors:  Yukio Yamori; Takashi Taguchi; Atsumi Hamada; Kazuhiro Kunimasa; Hideki Mori; Mari Mori
Journal:  J Biomed Sci       Date:  2010-08-24       Impact factor: 8.410

7.  The potential health benefits of taurine in cardiovascular disease.

Authors:  Yan-Jun Xu; Amarjit S Arneja; Paramjit S Tappia; Naranjan S Dhalla
Journal:  Exp Clin Cardiol       Date:  2008

Review 8.  Taurine supplementation in spontaneously hypertensive rats: Advantages and limitations for human applications.

Authors:  Atchariya Suwanich; J Michael Wyss; Sanya Roysommuti
Journal:  World J Cardiol       Date:  2013-11-26

Review 9.  The Effects of Oral Taurine on Resting Blood Pressure in Humans: a Meta-Analysis.

Authors:  Mark Waldron; Stephen David Patterson; Jamie Tallent; Owen Jeffries
Journal:  Curr Hypertens Rep       Date:  2018-07-13       Impact factor: 5.369

10.  Protective role of taurine against oxidative stress (Review).

Authors:  Stella Baliou; Maria Adamaki; Petros Ioannou; Aglaia Pappa; Mihalis I Panayiotidis; Demetrios A Spandidos; Ioannis Christodoulou; Anthony M Kyriakopoulos; Vassilis Zoumpourlis
Journal:  Mol Med Rep       Date:  2021-06-29       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.